Fermenta Biotech Limited has announced it will hold a one-to-one investor meeting on May 28, 2026. The meeting will be conducted in physical mode in Mumbai. This disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company specified that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. It also noted that changes to the schedule may occur due to exigencies on the part of the company or investors.

Meeting Details

The company provided the following specifics regarding the upcoming interaction:

Investor Presentation

Fermenta Biotech informed that the Investor Presentation proposed to be discussed during the meeting will be uploaded on its website and on the BSE Limited's website. This upload is scheduled to take place after the Board Meeting set to be held on May 26, 2026.

Fermenta Biotech Limited filed a newspaper publication notice with BSE Limited on May 7, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was published in Business Standard, Mumbai (English version) and Sakal, Mumbai (Marathi version), and was submitted by Company Secretary & Head – Legal, Varadvinayak Khambete, under reference number F.No.: 908.

Notice to Equity Shareholders Regarding IEPF Transfer

In accordance with Section 124(6) and other applicable provisions of the Companies Act, 2013, read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, Fermenta Biotech notified its equity shareholders of the impending transfer of shares to the Investor Education and Protection Fund (IEPF) Demat Account. As per the applicable rules, all shares in respect of which dividend has remained unpaid or unclaimed for seven consecutive years or more are required to be transferred to the IEPF Demat Account.

Key Details of the Notice

The following table summarises the key parameters of the notice issued by Fermenta Biotech:

Shareholder Action Required

Fermenta Biotech communicated individually to concerned shareholders at their latest available addresses, informing them of the requirement to claim unpaid dividends. The company also uploaded details of such shareholders, along with equity shares due for transfer, on its website at www.fermentabiotech.com .

Shareholders were advised to make an application to the company and/or its Registrar and Transfer Agents by Wednesday, July 15, 2020, with a request for claiming unpaid dividends for financial years commencing from 2018-19 (final dividend). Failure to respond by this deadline would result in the company proceeding to transfer the respective shares to the IEPF Demat Account without further notice.

Mode of Transfer

The notice outlined two modes of share transfer to the IEPF Demat Account, depending on how the shares are held:

• Equity shares held in physical form: Duplicate share certificates or letters of confirmation will be issued, and the concerned depository will convert these into dematerialised form before transferring to the IEPF Demat Account. Original share certificates will stand automatically cancelled and deemed non-negotiable.
• Equity shares held in dematerialisation mode: Shares will be transferred directly to the dematerialised account of the IEPF Demat Account.

KYC Compliance Requirement

Fermenta Biotech also noted that as per SEBI Circular dated March 16, 2023 and other relevant circulars, outstanding payments in respect of equity shares will be credited directly to the bank accounts of shareholders holding equity shares in physical form only if the folio is KYC compliant. Both the dividend and equity shares transferred to IEPF/IEPF Demat Account, including all benefits accruing on such equity shares, can be claimed by the concerned equity shareholders from the IEPF Authority as per the procedure prescribed in the applicable rules.